U.S. Wireless Telecom Stock News

Investors may be considering whether YETI Holdings, at around US$37.32, is offering fair value right now or if the current price is out of line with its fundamentals. The stock shows a mixed return profile, with a 2.6% move over the last 7 days, a 1.6% decline over 30 days, a 16.8% decline year to date, a 28.4% gain over the past year, and a 55.8% decline over 5 years. Recent coverage of YETI has focused on its position in premium drinkware and coolers and how brand strength may influence...

Hyatt Hotels (H) has been busy adding new flags, from agreements for Grand Hyatt Chennai ECR and Hyatt House Bengaluru Devanahalli in India to fresh openings in Chattanooga and Niagara Falls. Investors now have more growth initiatives to assess. See our latest analysis for Hyatt Hotels. At a share price of $155.69, Hyatt has seen a 2.64% 1 day share price return and an 8.52% 7 day share price return. The 90 day share price return of 7.43% contrasts with a 1 year total shareholder return of...

Constellation Brands (STZ) has just wrapped up FY 2026 with fourth quarter revenue of US$1,920.2 million and basic EPS of US$1.16. The latest trailing twelve month figures show revenue of US$9.1 billion and EPS of US$9.62. Over recent periods, quarterly revenue has ranged from US$1,920.2 million to US$2,515 million, with basic EPS between US$1.16 and US$3.40. This sets up a picture of earnings that now sit against a return to profitability on a trailing basis and margins that investors will...

Hubbell recently reported a past quarter of double-digit growth in net sales, operating profit and diluted EPS, with earnings surpassing analyst expectations even as its full-year earnings guidance came in below consensus forecasts. This combination of strong recent execution and more cautious forward guidance highlights how management is balancing current momentum with prudence about the operating backdrop. Next, we'll examine how this strong earnings beat but softer full-year outlook may...

Nektar Therapeutics (NKTR) is back in focus after new Phase 2b data for rezpegaldesleukin in atopic dermatitis and alopecia areata at the 2026 American Academy of Dermatology meeting, alongside ongoing securities litigation tied to earlier trial conduct. See our latest analysis for Nektar Therapeutics. Rezpegaldesleukin’s new Phase 2b data and plans for a Phase 3 atopic dermatitis program arrive after a sharp swing in sentiment, with a 90 day share price return of 96.05% and a very large 1...

CDW (CDW) is back in focus after a steep slide, as investors rotate out of defensive IT names and question how generative AI, tighter enterprise IT budgets, and a challenged PC refresh cycle could reshape its model. See our latest analysis for CDW. Those worries have already fed into the trading pattern, with the share price moving to US$126.75 after a recent rebound. However, a 90 day share price return of a 5.05% decline and a 1 year total shareholder return of a 12.15% decline highlight...

In recent days, Hut 8 has drawn attention after its River Bend AI data center project and long-term leases with Anthropic, Alphabet, and Google, including a 15-year, US$7.00 billion agreement and a separate 15-year lease that could reach up to US$17.70 billion in revenues, moved further into focus. These multi-decade, hyperscale AI contracts mark a shift toward infrastructure-like, recurring revenue that could materially change how investors view Hut 8’s business mix versus pure Bitcoin...

Charles Schwab (NYSE:SCHW) is launching direct spot Bitcoin and Ethereum trading for its brokerage clients. The new crypto trading capability expands Schwab's digital asset offering beyond indirect products. This move places Schwab in more direct competition with other large financial firms offering crypto access. At a share price of $97.27, Charles Schwab enters this new line of business after a period of mixed returns, with the stock up 3.7% over the past week and 4.4% over the past...

Recent performance snapshot Apple Hospitality REIT (APLE) has drawn investor attention after a recent uptick, with the stock up 3.2% over the past day and 7.5% over the past week, finishing yesterday at US$12.40. See our latest analysis for Apple Hospitality REIT. The recent move to US$12.40 comes after a 7.6% 7 day share price return, set against a softer 90 day share price return and a 1 year total shareholder return of 18.9%. This points to momentum that has been stronger over the longer...

In early April 2026, the Ultra Accelerator Link Consortium ratified updated UALink specifications introducing In-Network Compute, chiplet integration, and standardized manageability to support more efficient, multi-vendor AI accelerator connectivity at scale. This move strengthens the ecosystem around open, interoperable AI interconnects, directly relevant to Astera Labs’ focus on UALink-based products and rack-scale AI infrastructure solutions. We’ll now examine how the new UALink...

T. Rowe Price has entered the market as an issuer of collateralized loan obligations with the launch of ROWE CLO 2026-1 Ltd., a US$403.59 million vehicle backed mainly by broadly syndicated first-lien bank loans and managed through T. Rowe Price Associates. This move extends the firm’s fixed income platform into securitized credit, drawing on its long-standing bank loan and CLO investing capabilities to offer higher-income credit strategies to institutional clients. We’ll now explore how T...

Gap Inc. (NYSE:GAP) is hosting the inaugural IDEASF forum at its San Francisco headquarters. The event brings together city leaders, companies such as McKinsey and Bank of America, and community groups to discuss civic engagement and business collaboration. The forum focuses on ideas to support San Francisco’s role as a center for creativity, technology, and retail. Gap Inc., best known for its portfolio of apparel brands and global retail presence, is using the IDEASF forum to highlight...

In early April 2026, Aura Minerals Inc. reported updated Mineral Reserves and Resources for six operating mines and several development projects, reflecting new drilling data, revised geological models, updated cost assumptions, and commodity price changes across its portfolio. An interesting aspect of the update is the mix of reserve growth and grade or metal content reductions, alongside substantial increases in inferred resources at assets like Almas, which together reshape how much...

Investors may be wondering whether Moderna's share price still makes sense after recent swings, or if the value case has already played out. Moderna closed at US$51.28, with returns of 4.2% over 7 days, a 6.7% decline over 30 days, a 66.2% gain year to date, and a 109.3% gain over 1 year, while 3 and 5 year returns sit at 68.1% and 67.9% declines. These moves have put fresh attention on how the market is currently pricing Moderna and whether recent momentum aligns with the underlying...

If you are wondering whether FedEx at US$377 is still offering value after a strong run, this article will help you unpack what the current price might be implying. The stock has logged returns of 4.3% over the last 7 days, 4.9% over the last 30 days, 28.6% year to date, and 86.7% over the last 1 year, which naturally raises questions about how much of the story is already in the price and how much risk you are now taking on. Recent coverage has focused on FedEx as a key player in global...

Wondering if Popular at US$146.82 is still offering value after a strong run, or if most of the opportunity is already priced in. The stock has recently posted returns of 7.3% over 7 days, 13.1% over 30 days, 16.6% year to date and 82.8% over 1 year, with a 3 year return of 168.4% and a 5 year return of 134.8%. These moves have prompted fresh interest from investors looking to understand what is driving sentiment around the bank. Broader sector attention on banks and their balance sheet...

Wondering whether Penumbra at around US$329.52 is priced for opportunity or already reflects high expectations? This article walks you through the numbers so you can judge how its current market value stacks up. The stock is roughly flat over the last week with a 0.3% decline, slightly weaker over the past month with a 2.1% decline, yet it still shows a 6.5% return year to date and a 22.7% return over the last year. Recent attention on Penumbra has centered on its position in the Medical...

If you are wondering whether Johnson & Johnson at around US$241 a share is still reasonably priced or already stretched, the next sections will walk through what the current valuation is actually telling you. The stock has had a mixed run lately, with a 0.7% decline over the last week and a 1.0% decline over the last month, yet it still sits on a 16.4% return year to date and 66.8% over the last year. Those moves sit against a backdrop of ongoing attention on Johnson & Johnson as a large...

In early April 2026, Scotiabank downgraded Equinix to Sector Perform, citing valuation concerns after the company’s strong run and premium earnings multiple, even as it continued to post record AI-driven data center bookings and double-digit revenue guidance for 2026. The downgrade came despite Equinix’s 11-year streak of dividend growth and growing exposure to AI workloads, underscoring tensions between robust fundamentals and a high market valuation. We’ll now examine how Scotiabank’s...

Bath & Body Works (BBWI) is leaning into the long running appeal of its Japanese Cherry Blossom line by re-releasing legacy scents, launching Forever Cherry Blossom, and pairing the rollout with broad “buy 3, get 1 free” promotions. See our latest analysis for Bath & Body Works. Despite the attention on Japanese Cherry Blossom and Forever Cherry Blossom, the share price is US$18.42 and the 30 day share price return of 9.88% and 1 year total shareholder return of 30.91% point to fading...

QUALCOMM (NasdaqGS:QCOM) is partnering with Silex Technology and Edge Impulse to expand its edge AI platforms into industrial automation and healthcare. The collaboration focuses on deploying advanced AI at the device level for connected medical equipment and factory systems. This move reflects QUALCOMM's effort to broaden its business beyond handset related revenue. For investors watching NasdaqGS:QCOM, this edge AI push comes as the share price sits at $127.75 and longer term returns have...

For investors wondering if Waters at around US$317 a share represents good value or too much optimism, this breakdown looks at what the current price really implies. The stock has recently moved 4.4% over the last 7 days and 6.0% over the last 30 days, while the year-to-date return sits at a 16.8% decline and the 1-year return is 1.0%. Recent coverage has focused on how investors are reassessing high quality life sciences names like Waters in light of changing expectations for growth and...

In the past week, LyondellBasell Industries was hit by shifting geopolitical sentiment as the US-Iran ceasefire eased the recent conflict-driven support for energy and basic materials stocks, reversing earlier optimism tied to disrupted competitor supply routes. At the same time, upcoming first-quarter 2026 results and cautious analyst commentary about earlier gains running too far have sharpened investor focus on how LyondellBasell’s underlying chemicals business performs without a...

If you are wondering whether Spectrum Brands Holdings at about US$80.22 is offering fair value or hiding a margin of safety, you are asking the right question. The stock has delivered returns of 8.8% over the last 7 days, 6.2% over 30 days, 33.6% year to date and 35.2% over the last year, which naturally raises questions about how much of the story is already in the price. Recent coverage around Spectrum Brands Holdings has focused on its role in the Household Products space and how...